Search Results - "GULERIA, Indira"

Refine Results
  1. 1

    Glioproliferative Lesion of the Spinal Cord as a Complication of “Stem-Cell Tourism” by Berkowitz, Aaron L, Miller, Michael B, Mir, Saad A, Cagney, Daniel, Chavakula, Vamsidhar, Guleria, Indira, Aizer, Ayal, Ligon, Keith L, Chi, John H

    Published in The New England journal of medicine (14-07-2016)
    “…A primitive neoplasm composed predominantly of nonhost cells was detected in the thoracic spinal cord and thecal sac of a 66-year-old man who had received…”
    Get full text
    Journal Article
  2. 2

    Immune-checkpoint proteins VISTA and PD-1 nonredundantly regulate murine T-cell responses by Liu, Jun, Yuan, Ying, Chen, Wenna, Putra, Juan, Suriawinata, Arief A., Schenk, Austin D., Miller, Halli E., Guleria, Indira, Barth, Richard J., Huang, Yina H., Wang, Li

    “…Significance Multiple immune-checkpoint proteins, such as programmed death 1 (PD-1), LAG3, and TIM3, are coexpressed on immune cells and functionally synergize…”
    Get full text
    Journal Article
  3. 3

    Maternal Acceptance of the Fetus: True Human Tolerance by Guleria, Indira, Sayegh, Mohamed H

    Published in Journal of Immunology (15-03-2007)
    “…Induction and maintenance of immunologic tolerance in humans remains a desirable but elusive goal. Therefore, understanding the physiologic mechanisms of…”
    Get full text
    Journal Article
  4. 4

    Clonal dynamics of alloreactive T cells in kidney allograft rejection after anti-PD-1 therapy by Dunlap, Garrett S., DiToro, Daniel, Henderson, Joel, Shah, Sujal I., Manos, Mike, Severgnini, Mariano, Weins, Astrid, Guleria, Indira, Ott, Patrick A., Murakami, Naoka, Rao, Deepak A.

    Published in Nature communications (21-03-2023)
    “…Kidney transplant recipients are at particular risk for developing tumors, many of which are now routinely treated with immune checkpoint inhibitors (ICIs);…”
    Get full text
    Journal Article
  5. 5

    Role of PD1/PDL1 pathway, and TH17 and treg cells in maternal tolerance to the fetus by Tripathi, Sudipta, Guleria, Indira

    Published in Biomedical journal (01-01-2015)
    “…Tolerance of the fetus by the maternal immune system is regulated through various mechanisms involving the different immune cells, both in the periphery and…”
    Get full text
    Journal Article
  6. 6

    Programmed death 1 ligand signaling regulates the generation of adaptive Foxp3⁺CD4⁺ regulatory T cells by Wang, Li, Pino-Lagos, Karina, de Vries, Victor C, Guleria, Indira, Sayegh, Mohamed H, Noelle, Randolph J

    “…Although mature dendritic cells (DCs) are potent initiators of adaptive immune response, immature steady-state DCs contribute to immune tolerance. In this…”
    Get full text
    Journal Article
  7. 7

    The link between the PDL1 costimulatory pathway and Th17 in fetomaternal tolerance by D'Addio, Francesca, Riella, Leonardo V, Mfarrej, Bechara G, Chabtini, Lola, Adams, La Tonya, Yeung, Melissa, Yagita, Hideo, Azuma, Miyuki, Sayegh, Mohamed H, Guleria, Indira

    Published in The Journal of immunology (1950) (01-11-2011)
    “…Fetomaternal tolerance has been shown to depend both on regulatory T cells (Tregs) and negative signals from the PD1-PDL1 costimulatory pathway. More recently,…”
    Get full text
    Journal Article
  8. 8

    TIM-3 regulates innate immune cells to induce fetomaternal tolerance by Chabtini, Lola, Mfarrej, Bechara, Mounayar, Marwan, Zhu, Bing, Batal, Ibrahim, Dakle, Pranal J, Smith, Brian D, Boenisch, Olaf, Najafian, Nader, Akiba, Hisaya, Yagita, Hideo, Guleria, Indira

    Published in The Journal of immunology (1950) (01-01-2013)
    “…TIM-3 is constitutively expressed on subsets of macrophages and dendritic cells. Its expression on other cells of the innate immune system and its role in…”
    Get full text
    Journal Article
  9. 9

    Insulin-induced remission in new-onset NOD mice is maintained by the PD-1-PD-L1 pathway by Fife, Brian T, Guleria, Indira, Gubbels Bupp, Melanie, Eagar, Todd N, Tang, Qizhi, Bour-Jordan, Helene, Yagita, Hideo, Azuma, Miyuki, Sayegh, Mohamed H, Bluestone, Jeffrey A

    Published in The Journal of experimental medicine (27-11-2006)
    “…The past decade has seen a significant increase in the number of potentially tolerogenic therapies for treatment of new-onset diabetes. However, most…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Biomarkers in Fetomaternal Tolerance by Tripathi, Sudipta, PhD, Guleria, Indira, PhD, D(ABHI)

    Published in Clinics in laboratory medicine (01-03-2019)
    “…Multiple mechanisms of tolerance operate in the immune cross-talk at the fetomaternal interface, contributing to successful pregnancy outcome. The cross-talk…”
    Get full text
    Journal Article
  12. 12

    Ischemia augments alloimmune injury through IL-6-driven CD4+ alloreactivity by Uehara, Mayuko, Solhjou, Zhabiz, Banouni, Naima, Kasinath, Vivek, Xiaqun, Ye, Dai, Li, Yilmam, Osman, Yilmaz, Mine, Ichimura, Takaharu, Fiorina, Paolo, Martins, Paulo N., Ohori, Shunsuke, Guleria, Indira, Maarouf, Omar H., Tullius, Stefan G., McGrath, Martina M., Abdi, Reza

    Published in Scientific reports (06-02-2018)
    “…Ischemia reperfusion injuries (IRI) are unavoidable in solid organ transplantation. IRI augments alloimmunity but the mechanisms involved are poorly…”
    Get full text
    Journal Article
  13. 13
  14. 14

    A critical role for the programmed death ligand 1 in fetomaternal tolerance by Guleria, Indira, Khosroshahi, Arezou, Ansari, Mohammed Javeed, Habicht, Antje, Azuma, Miyuki, Yagita, Hideo, Noelle, Randolph J, Coyle, Anthony, Mellor, Andrew L, Khoury, Samia J, Sayegh, Mohamed H

    Published in The Journal of experimental medicine (18-07-2005)
    “…Fetal survival during gestation implies that tolerance mechanisms suppress the maternal immune response to paternally inherited alloantigens. Here we show that…”
    Get full text
    Journal Article
  15. 15

    Blockade of the programmed death-1 (PD1) pathway undermines potent genetic protection from type 1 diabetes by Kochupurakkal, Nora M, Kruger, Annie J, Tripathi, Sudipta, Zhu, Bing, Adams, La Tonya, Rainbow, Daniel B, Rossini, Aldo, Greiner, Dale L, Sayegh, Mohamed H, Wicker, Linda S, Guleria, Indira

    Published in PloS one (28-02-2014)
    “…Inhibition of PD1-PDL1 signaling in NOD mice accelerates onset of type 1 diabetes implicating this pathway in suppressing the emergence of pancreatic beta cell…”
    Get full text
    Journal Article
  16. 16

    Effect of TIM-3 Blockade on the Immunophenotype and Cytokine Profile of Murine Uterine NK Cells by Tripathi, Sudipta, Chabtini, Lola, Dakle, Pranal J, Smith, Brian, Akiba, Hisaya, Yagita, Hideo, Guleria, Indira

    Published in PloS one (21-04-2015)
    “…NK cells are the most abundant lymphocyte population in the feto-maternal interface during gestation. The uterine NK cells (uNK) are transient, have a unique…”
    Get full text
    Journal Article
  17. 17

    Targeting CD22 Reprograms B-Cells and Reverses Autoimmune Diabetes by FIORINA, Paolo, VERGANI, Andrea, RODIG, Scott, DUNUSSI-JOANNOPOULOS, Kyri, BLUESTONE, Jeffrey, SAYEGH, Mohamed H, DADA, Shirine, JUREWICZ, Mollie, WONG, Masie, LAW, Kenneth, ERXI WU, ZE TIAN, ABDI, Reza, GULERIA, Indira

    Published in Diabetes (New York, N.Y.) (01-11-2008)
    “…Targeting CD22 Reprograms B-Cells and Reverses Autoimmune Diabetes Paolo Fiorina 1 2 , Andrea Vergani 1 2 , Shirine Dada 1 , Mollie Jurewicz 1 , Masie Wong 1 ,…”
    Get full text
    Journal Article
  18. 18

    Association of Donor and Recipient Telomere Length with Clinical Outcomes following Lung Transplantation by Courtwright, Andrew M, Fried, Sabrina, Villalba, Julian A, Moniodis, Anna, Guleria, Indira, Wood, Isabelle, Milford, Edgar, Mallidi, Hari H, Hunninghake, Gary M, Raby, Benjamin A, Agarwal, Suneet, Camp, Philip C, Rosas, Ivan O, Goldberg, Hilary J, El-Chemaly, Souheil

    Published in PloS one (02-09-2016)
    “…Patients with short telomere syndromes and pulmonary fibrosis have increased complications after lung transplant. However, the more general impact of donor and…”
    Get full text
    Journal Article
  19. 19
  20. 20